Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/19/2014 | CN103649097A Novel cephalosporins used as antibacterial agents |
03/19/2014 | CN103649094A Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
03/19/2014 | CN103649093A Substituted imidazopyridines and imidazopyridazines and the use thereof |
03/19/2014 | CN103649091A Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts |
03/19/2014 | CN103649090A Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof |
03/19/2014 | CN103649089A Pyrrolotriazinone derivatives as PI3K inhibitors |
03/19/2014 | CN103649088A 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections |
03/19/2014 | CN103649087A Substituted imidazopyridines and intermediates thereof |
03/19/2014 | CN103649086A Methods for preparing naphthyridines |
03/19/2014 | CN103649085A Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
03/19/2014 | CN103649084A 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof |
03/19/2014 | CN103649082A Pyridine derivative and bace-1 inhibitor containing same |
03/19/2014 | CN103649079A Hepatitis C inhibitors and uses thereof |
03/19/2014 | CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases |
03/19/2014 | CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors |
03/19/2014 | CN103649074A Substituted azaheterocycles for the treatment of cancer |
03/19/2014 | CN103649073A 17alpha-hydroxylase/c17,20-lyase inhibitors |
03/19/2014 | CN103649072A 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use |
03/19/2014 | CN103649066A 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof |
03/19/2014 | CN103649062A Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
03/19/2014 | CN103649061A Pheno thiazine diaminium salts and their use |
03/19/2014 | CN103649059A 5-membered ring aromatic heterocyclic derivative having NPY Y5 receptor antagonistic activity |
03/19/2014 | CN103649055A Method for manufacturing pyrazole derivative |
03/19/2014 | CN103649053A Aminomethyl quinolone compounds |
03/19/2014 | CN103649048A Indoleamine derivatives for the treatment of central nervous system diseases |
03/19/2014 | CN103649033A Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbasugars |
03/19/2014 | CN103649031A Prenylated hydroxystilbenes |
03/19/2014 | CN103649028A Chrysophaentin analogs that inhibit FtsZ protein |
03/19/2014 | CN103649019A Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia |
03/19/2014 | CN103648588A Compounds for the treatment of cancers associated with human papillomavirus |
03/19/2014 | CN103648531A Method for prevention or treatment of metabolic syndrome |
03/19/2014 | CN103648530A Protein-active agent conjugates and method for preparing the same |
03/19/2014 | CN103648522A Treatment of microbial infections |
03/19/2014 | CN103648521A Intravascular delivery of nanoparticle compositions and uses thereof |
03/19/2014 | CN103648520A Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients |
03/19/2014 | CN103648519A Pharmaceutical combination for use in the treatment of diabetes type 2 patients |
03/19/2014 | CN103648506A SUMOylation of SERCA2A and cardiovascular disease |
03/19/2014 | CN103648505A Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer |
03/19/2014 | CN103648504A Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome |
03/19/2014 | CN103648503A Treatment of excessive menstrual bleeding associated with uterine fibroids |
03/19/2014 | CN103648502A Pharmaceutical composition containing oleanolic acid acetate as an active ingredient for preventing or treating TLR- or IL-6-mediated diseases |
03/19/2014 | CN103648501A Induction of immune tolerance by using methotrexate |
03/19/2014 | CN103648500A Methods and use of bifunctional enzyme-building clamp-shaped molecules |
03/19/2014 | CN103648499A Processes for preparing isoquinolinones and solid forms of isoquinolinones |
03/19/2014 | CN103648498A Pharmaceutical combination |
03/19/2014 | CN103648497A Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance |
03/19/2014 | CN103648496A Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
03/19/2014 | CN103648495A Method of treating atherosclerosis in high triglyceride subjects |
03/19/2014 | CN103648494A DHA and EPA in the reduction of oxidative stress |
03/19/2014 | CN103648493A Subcutaneously infusible levodopa prodrug compositions and methods of infusion |
03/19/2014 | CN103648492A Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors |
03/19/2014 | CN103648491A Methods and pharmaceutical compositions for inhibiting influenza viruses replication |
03/19/2014 | CN103648490A Use of intracellular enzymes for the release of covalently linked bioactives |
03/19/2014 | CN103648489A Multiple antigen presenting immunogenic composition, and methods and uses thereof |
03/19/2014 | CN103648488A Drug combinations and uses in treating a coughing condition |
03/19/2014 | CN103648487A Drug delivery system |
03/19/2014 | CN103648486A Sustained release paracetamol formulations |
03/19/2014 | CN103648485A Pharmaceutical composition of rosuvastatin calcium |
03/19/2014 | CN103648482A Intravaginal delivery system |
03/19/2014 | CN103648307A Edible composition |
03/19/2014 | CN103648306A Serum cholesterol lowering drink and an improved method for lowering cholesterol |
03/19/2014 | CN103648282A Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections |
03/19/2014 | CN103648279A Treatment of disease with poly-n-acety glucosamine nanofibers |
03/19/2014 | CN103641925A Covalent polycompound of water-soluble polysaccharide and taxane compound, and preparation method and medical application of covalent polycompound |
03/19/2014 | CN103641882A Novel 2,3-dihydroxyl-30-noroleanolic acid as well as preparation method and application thereof in preparing glycosidase inhibitor medicament |
03/19/2014 | CN103641871A Macrocyclic polyphenol compound, and preparation and application thereof in pharmacy |
03/19/2014 | CN103641841A Sesquiterpene lactone compounds as well as preparation method and application thereof |
03/19/2014 | CN103641834A Pyrrolobenzodiazepine compounds, and preparation method and application thereof |
03/19/2014 | CN103641833A Compounds and compositions as protein kinase inhibitors |
03/19/2014 | CN103641829A Triazole derivatives as kinase inhibitors |
03/19/2014 | CN103641828A Triazolonaphthyridine-one derivative compound and preparation method and application thereof |
03/19/2014 | CN103641827A Purrocoline derivative and synthetic method and application thereof |
03/19/2014 | CN103641823A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
03/19/2014 | CN103641822A Canagliflozin compound and pharmaceutical composition thereof |
03/19/2014 | CN103641818A Novel crystal form of tandospirone citrate, preparation method and applications |
03/19/2014 | CN103641817A Novel crystal form of tandospirone citrate, preparation method and applications |
03/19/2014 | CN103641816A Compounds and compositions as protein kinase inhibitors |
03/19/2014 | CN103641814A 4'-O-substituted isoindoline derivatives and compositions comprising and methods of using the same |
03/19/2014 | CN103641807A Extraction method of apigenin, pharmaceutical composition for treating diabetes and application thereof |
03/19/2014 | CN103641794A Sulfonium compounds and their use |
03/19/2014 | CN103641791A Cyclopeptide compound clavatustide B, and preparation method and application thereof |
03/19/2014 | CN103641774A Preparation method of benidipine hydrochloride |
03/19/2014 | CN103641767A Substituted phenylindolyl selenide, selenoxide, selenone and application as tumor cell proliferation inhibitor |
03/19/2014 | CN103641764A Pharmaceutical composition for regulating blood lipid |
03/19/2014 | CN103641762A Transient receptor potential vanilloid 1/epoxidase 2(TRPV1/COX-2) dual inhibitor, and preparation method and application thereof in preparation of analgesic medicament |
03/19/2014 | CN103641713A Preparation method and application of monoglyceride derivative |
03/19/2014 | CN103641712A Hydroxyl acetylated curcumin and application thereof in preparation of ultrasonic sensitive agent for treating atherosclerosis |
03/19/2014 | CN103641688A Mailuoning dihydroanthracene as well as preparation method and use thereof |
03/19/2014 | CN103638563A Biological liquid of biological albumin glue |
03/19/2014 | CN103638535A B ultrasound coupling agent containing traditional Chinese components |
03/19/2014 | CN103638530A Alginic acid-adriamycin amycin bonding medicine and preparation method thereof |
03/19/2014 | CN103638529A Preparation method of medicament for enriching blood |
03/19/2014 | CN103638528A Folic acid targeted nano-particle as well as application and synthesis and detection method thereof |
03/19/2014 | CN103638523A Medicinal composition containing donepezil or its pharmaceutically acceptable salt and beta-receptor blocker |
03/19/2014 | CN103638515A Anti gram-positive bacterium composition of anglerfish skin collagen peptide |
03/19/2014 | CN103638459A Traditional Chinese medicine composition for preventing and treating virus meningitis and preparation method thereof |
03/19/2014 | CN103638432A Traditional Chinese medicine eye drop |
03/19/2014 | CN103638414A Traditional Chinese medicine composition capable of relieving pain |
03/19/2014 | CN103638404A Detoxifying, itching relieving and sterilizing ointment and preparation method thereof |
03/19/2014 | CN103638364A Medicament for treating anaphylaxis skin disease |